Immune cell identity behind the Ktrans mapping of mouse glioblastoma
Magnetic Resonance Imaging · 2023
DOI: 10.1016/j.mri.2023.06.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance Imaging, 2023. Verfasst von Yanrong Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; Stanford Shared FACS Facility, Stanford University, CA, USA. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Dynamic contrast-enhanced MR imaging (DCE-MRI) can assess the integrity of the blood brain barrier (BBB) and has been used in GBM patients to determine glioma grade, predict prognosis, evaluate treatment response, and differentiate treatment-induced effect from recurrence. The volume transfer constant Ktrans is the most frequently used metric in tumor assessment. Based on previous studies that a higher WHO grade of brain tumor was associated with greater impairments of immunity and that Ktrans value was associated with the pathological grading, the relationship between differential composition of immune cells in GBM tissue and dynamic changes in Ktrans mapping was anticipated in this study. The present study utilized an orthotopic allograft model of GBM in which mouse GL26 cells are implanted into Ccr2RFP/wtCx3cr1GFP/wt mice on a C57 background. The brain tumors exhibited heterogenous Ktrans values with the coefficients of variation (CV) above 75%, or relatively homogeneous Ktrans maps with CV values below 50%. The Ktrans values of homogeneous tumors ranged between 0.02/min-0.32/min with a median value of 0.10/min. The immune cell composition defined by quantitative immunohistochemistry and cell sorting was compared between the tumors with Ktrans values above 0.10/min (higher Ktrans) or below 0.10/min (lower Ktrans). Histological analysis showed that tumors with higher Ktrans values exhibited greater numbers of CCR2pos cells (257.60 ± 16.42/mm2 vs 203.23 ± 12.20/mm2, p = 0.04) and an increased ratio of CCR2pos cells to CX3CR1pos cells (1.20 ± 0.02 vs 0.38 ± 0.04, p = 0.001), the numbers of CX3CR1pos cells did not differ significantly based on Ktrans values (219.70 ± 16.20/mm2 vs 250.38 ± 21.20/mm2, p = 0.19). Flowcytometry analysis showed that tumors with higher Ktrans values (above 0.1/min) were associated with greater numbers of both overall monocytes (54.93 ± 6.81% vs 29.75 ± 3.54%, p = 0.01) and inflammatory monocytes (72.38 ± 1.49% vs 59.52 ± 2.44%, p = 0.001). In contrast, tumors with lower Ktrans values (below 0.1/min) exhibited greater numbers of patrolling monocytes (75.65 ± 4.14% vs 63 ± 6.94%, p = 0.05). In the tumors with lower Ktrans values, all three types of tumor associated cells, including patrolling monocytes, inflammatory monocytes, and microglia cells possessed a higher proportion of cells at pro-inflammatory status (41.77 ± 6.13% vs 25.06 ± 6.72%, p = 0.05; 27.50 ± 2.11% vs 20.62 ± 1.87%, p = 0.03; and 55.80 ± 9.88% vs 31.12 ± 7.31%, p = 0.05), inflammatory monocytes showed fewer anti-inflammatory cells (1.25 ± 0.62% vs 3.16 ± 3.56%, p = 0.04). Taken together, differences in Ktrans values were associated with differential immune cell phenotypes and polarizations. Ktrans mapping may therefore represent a novel approach for defining the immune status of GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; Stanford Shared FACS Facility, Stanford University, CA, USA.
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; In Vivo Imaging Facility, Quantitative Biology Unit, Luxembourg Institute of Health Transversal Activities, 84 Val Fleuri, L-1526, Luxembou…
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Oncology, Luxembourg Institute of Health, 84, Val Fleuri, L-1526, Luxembourg.
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Diagnostic and Public Health, University of Verona, Verona 37135, Italy.
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jing-wu Road, Jinan 250021, Chin…
- Department of Radiology, Neuroradiology Division, Stanford University, CA, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Zhang, Y., Keunen, O., Golebiewska, A., Gerosa, M., Wang, J., Ghobadi, S. N., Huang, A., Hou, Q., Habte, F. G., Li, N., Grant, G., Paulmurugan, R., Lee, K. S., & Wintermark, M. (2023). Immune cell identity behind the Ktrans mapping of mouse glioblastoma. Magnetic Resonance Imaging. https://doi.org/10.1016/j.mri.2023.06.008
Vancouver
Zhang Y, Keunen O, Golebiewska A, Gerosa M, Wang J, Ghobadi SN, et al. Immune cell identity behind the Ktrans mapping of mouse glioblastoma. Magnetic Resonance Imaging. 2023. doi:10.1016/j.mri.2023.06.008
BibTeX
@article{Zhang2023,
author = {Zhang, Yanrong and Keunen, Olivier and Golebiewska, Anna and Gerosa, Marco and Wang, Jing and Ghobadi, Sara Natasha and Huang, Ai and Hou, Qingyi and Habte, Frezghi G and Li, Ningrui and Grant, Gerry and Paulmurugan, Ramasamy and Lee, Kevin S and Wintermark, Max},
title = {Immune cell identity behind the Ktrans mapping of mouse glioblastoma},
journal = {Magnetic Resonance Imaging},
year = {2023},
doi = {10.1016/j.mri.2023.06.008}
}
EUVIMED